News

Goldman Sachs is signalling that the US Federal Reserve is unlikely to raise rates in September, suggesting the Fed may be nearing the end of its hiking cycle or considering a pause. This is significant because it shifts market expectations around inflation control and future monetary policy, potentially supporting equity valuations and risk assets. For Australian investors, a pause in US rate hikes could ease pressure on the RBA to continue tightening aggressively, supporting the AUD and improving conditions for ASX-listed companies with US earnings exposure.

Softer U.S. economic data is reducing expectations for further Federal Reserve rate hikes, which typically supports equity markets by lowering borrowing costs and boosting growth stocks. European markets are trading cautiously as investors digest the data and recalibrate inflation/growth outlooks. For Australian investors, this matters because a slower U.S. rate hiking cycle usually strengthens the AUD and reduces headwinds for ASX earnings—particularly tech and consumer stocks with U.S. exposure—though the RBA's own policy path remains the primary driver of local sentiment.

Market expectations for an imminent Federal Reserve rate hike are cooling, suggesting traders are pricing in a more patient stance from the central bank. This shift eases pressure on growth stocks and reduces near-term inflation concerns, though it depends on upcoming US retail earnings and economic data to confirm the trend. For Australian investors, a softer Fed outlook typically supports the AUD and reduces pressure on the RBA to maintain aggressive tightening, making this a meaningful macro signal to monitor heading into earnings season.

New home lending in Australia fell by $5.4 billion in the June quarter, driven by elevated interest rates and uncertainty around proposed federal property tax reforms. This sharp contraction signals weakening housing demand, which will pressure construction activity and bank mortgage portfolios—particularly concerning given banks derive substantial profits from residential lending. Watch for downstream impacts on building stocks and consumer confidence, plus political pressure around the property tax proposal as the market signals distress.

Victoria's teachers have secured a 28.3–32.4% pay rise over four years, making them Australia's highest-paid teachers and resolving a year-long industrial dispute. This outcome reflects broader wage pressure in Australia as unions leverage tight labour markets, particularly in essential services—a pattern the RBA is monitoring closely as it assesses inflation persistence. For Australian investors, this signals continued cost pressures on state budgets and potential flow-on wage claims in other public sectors, though it removes near-term industrial action risk in education.

Mesoblast has finished enrolling and treating patients in a Phase 3 trial for its cell therapy targeting low back pain, with results expected in the coming months. This is a pivotal milestone for the ASX-listed biotech—a positive readout could unlock significant value and potential commercialisation pathway, while a miss could pressure the stock. Australian biotech investors should monitor the data release closely, as Mesoblast's pipeline success has direct implications for the company's valuation and its ability to fund future development.

Currency markets are repricing Fed rate hike expectations downward, which is strengthening the Japanese yen against the US dollar. This matters because it reflects shifting market bets on US monetary policy—likely due to economic softening data or recession concerns. For Australian investors, a stronger yen and weaker USD could support the AUD/USD, though it signals global growth concerns that could weigh on commodity currencies and ASX-listed exporters in the medium term.

ASX reporting season is delivering mixed results: JB Hi-Fi and NAB disappointed the market with weaker earnings, pressuring the financials and discretionary retail sectors. However, strength in gold and copper stocks—driven by commodity price strength—provided offsetting gains. For Australian investors, this highlights the rotation away from domestic consumer-facing stocks (hit by slowing spending and rising rates) toward resources benefiting from global demand and weaker AUD tailwinds. Watch earnings revisions for retailers and banks over coming weeks to gauge durability of the weakness.

Asian markets are showing mixed performance following weak US leads, with China rebounding despite broader regional uncertainty and Japan maintaining modest gains despite missing GDP expectations in Q2. This reflects the diverging economic narratives across major regions—weak US signals, Chinese recovery attempts, and Japan's growth slowdown—which typically pressures risk assets and creates volatility for Australian exporters and the ASX200. Australian investors should monitor how persistent US weakness affects capital flows and whether China's rebound can sustain momentum, as both directly influence commodity prices and local equity valuations.

Japan's Q2 GDP growth slowed to just 0.3% quarter-on-quarter, signalling weakening economic momentum in the world's third-largest economy. However, a rebound in industrial output to 1.9% suggests underlying demand may stabilise, though the modest GDP print points to softer consumer spending or investment. For Australian investors, this matters because slower Japanese growth could weigh on regional demand for commodities and manufacturing exports, while it may also keep the Bank of Japan cautious on tightening—potentially supporting the yen carry trade that affects AUD/JPY positioning.

Labor is introducing a centralised opt-out register for online gambling ads and imposing a new levy on gambling operators to fund it. While this falls short of a full advertising ban or opt-in model that advocates wanted, it represents meaningful regulatory tightening that will increase compliance costs for online betting companies operating in Australia. The levy structure directly impacts profitability for major ASX-listed gambling stocks like Pointsbet and Sportsbet's parent companies, though the measure addresses a politically sensitive issue around problem gambling that could attract further restrictions if adoption rates disappoint.

This piece explores diverging central bank paths: the Federal Reserve potentially pausing rate hikes if US consumer spending weakens, while Japan's central bank signals readiness to tighten policy after years of accommodation. The dynamic matters for Australian investors because Fed decisions drive USD strength and global risk appetite, while a hawkish BoJ shift could reshape Asia-Pacific currency relationships and bond markets. Watch upcoming US consumer data (retail sales, PCE inflation) and Japan's policy meetings for clarity on these trajectories.

A Guardian investigation suggests Microsoft may have overstated its AI infrastructure capacity relative to the advanced chips it actually has deployed, raising questions about the company's ability to deliver on AI commitments and compete with rivals. This matters because chip availability is a genuine bottleneck constraining AI development globally—if Microsoft is struggling to secure sufficient advanced semiconductors (likely Nvidia GPUs), it signals broader supply constraints that could delay AI product rollouts and impact the tech sector's growth narrative. Australian investors should watch for Microsoft's next earnings call commentary on capital expenditure and chip procurement, as any admission of supply constraints could pressure the entire AI-exposed tech sector and semiconductor stocks like Nvidia.

Japan's Q2 GDP growth disappointed relative to economist forecasts, dragged down by softer consumer spending and business investment—key components of domestic demand. This signals Japan's economic recovery may be losing momentum despite the BoJ's gradual rate hikes, raising questions about whether inflation is genuinely sustainable or whether demand is simply cooling. For Australian investors, weaker Japanese growth could dampen demand for our commodity exports and pressure the ASX200, while a stalling BoJ pivot could keep the yen softer for longer, benefiting exporters but pressuring the AUD in carry trade unwinds.

NAB delivered better-than-expected June quarter earnings, a positive signal for Australia's banking sector and economy. However, management's cautious housing outlook is the key takeaway—it suggests the bank expects softer property demand ahead, likely reflecting high interest rates and stretched household budgets. For Australian investors, this mixed signal matters because banks are both a earnings story and a proxy for economic health; a cautious NAB stance could weigh on other financials and reinforce expectations that the RBA may need to hold rates steady longer than some hoped.

Oncosil Medical has secured FDA clearance for its bile duct cancer treatment, marking a major regulatory win for the small-cap Australian biotech. This opens the US market—the world's largest pharma market—for a rare cancer indication, which could significantly boost revenue and reduce commercialisation risk. Australian investors should watch for upcoming quarterly updates on US launch timelines, uptake rates, and cash burn, as small-cap biotech stocks are sensitive to execution and funding needs.

Asian equity markets are treading water as geopolitical tensions in the Gulf region sustain elevated oil prices, creating uncertainty about the inflation outlook and central bank policy responses. Higher energy costs flow through to transport, consumer goods, and broader economic growth, which is particularly relevant for Australia given our energy import exposure and reliance on stable commodity markets. Watch for oil price movements (targeting support/resistance levels) and any escalation signals from the region—sustained oil elevation above $80–90/barrel could prompt central banks to recalibrate rate-cut expectations, pressuring growth stocks and weighing on ASX earnings forecasts.

Victorian teachers have voted to accept a new pay deal, ending months of industrial dispute with the state government. The 79% endorsement reduces immediate strike risk and associated disruption to schools and families. While this is positive for industrial relations stability, the resolution signals wage pressure in the public sector—relevant context for broader inflation and government spending debates that could influence RBA policy settings and fiscal outlook.

The Japanese yen is strengthening as market participants reduce bets on aggressive Federal Reserve rate hikes, typically a sign of shifting expectations around US monetary policy. A stronger yen reflects capital flowing into Japan and reduced appetite for higher US yields, which can affect currency pairs like AUD/USD and have flow-on effects for Australian exporters and import-competing industries. Australian investors should monitor this alongside RBA policy signals and Fed commentary, as currency moves influence everything from equity valuations to commodity prices denominated in USD.

Trump's request to reduce military exercises with South Korea signals a potential shift in US security posture in the Indo-Pacific, raising geopolitical uncertainty in a strategically critical region. This could embolden regional actors and destabilise the security architecture that's underpinned decades of stability—particularly concerning for Australia given our alliance relationships and exposure to Korean supply chains (semiconductors, defence). Australian investors should monitor how this affects US defence spending commitments and whether it influences regional defence budgets, including Australia's own strategic positioning.